Roche Holding AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RHHVF research report →
About the company
Roche Holding AG operates as a global healthcare leader, specializing in both pharmaceuticals and diagnostics. The company's reach extends across key markets like Switzerland, Germany, and the United States, in addition to its broader international footprint. Its extensive pharmaceutical division develops and offers treatments for a diverse range of conditions.
- CEO
- Thomas Schinecker
- IPO
- 2009
- Employees
- 103,249
- HQ
- Basel, CH
Price Chart
- Market Cap
- $327.35B
- P/E
- 21.05
- P/S
- 4.41
- P/B
- 8.02
- EV/EBITDA
- 13.18
- Div Yield
- 2.88%
- Gross Margin
- 73.53%
- Op Margin
- 31.32%
- Net Margin
- 20.94%
- ROE
- 41.23%
- ROIC
- 20.28%
- Revenue
- $61.55B · -1.36%
- Net Income
- $12.89B · 55.69%
- EPS
- $16.19 · 55.82%
- Op Income
- $16.37B
- FCF YoY
- -6.60%
- 52W High
- $490.33
- 52W Low
- $277.00
- 50D MA
- $448.13
- 200D MA
- $371.04
- Beta
- 0.34
- Avg Volume
- 27.56K
Get TickerSpark's AI analysis on RHHVF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RHHVF coverage
Recent articles, reports, and earnings notes.
No research on RHHVF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RHHVF report →Similar companies
Peers in the same neighborhood.